Home › Dyax Corp. Announces Expansion Of Phase 1b Clinical Trial For DX-2930
 

Keywords :   


Dyax Corp. Announces Expansion Of Phase 1b Clinical Trial For DX-2930

2014-11-05 07:17:01| drugdiscoveryonline Home Page

Dyax Corp. recently announced the expansion of its ongoing Phase 1b clinical trial evaluating DX-2930 to include additional patients and dosing cohorts

Tags: trial phase corp clinical

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
27.11 ( #1670 )
27.1117 AIR AGS 83M-S
27.11 XYZ 3
27.11XVSecret1
27.11NFT ADVANCE 3-370!
27.11 101
27.11
27.11 DESCENTE L
More »